देश: न्यूज़ीलैंड
भाषा: अंग्रेज़ी
स्रोत: Medsafe (Medicines Safety Authority)
Adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10mL adrenaline
Pfizer New Zealand Limited
Adrenaline acid tartrate 1.8 mg (Equiv to 1:10000 or 1 mg/10mL adrenaline)
1:10000
Solution for injection
Active: Adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10mL adrenaline Excipient: Sodium chloride Sodium metabisulfite Water for injection
Ampoule, glass, 10mL, 5 dose units
Restricted
Restricted
Boehringer Ingelheim Pharma GmbH & Co KG
For the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.
Package - Contents - Shelf Life: Ampoule, glass, 10mL - 5 dose units - 18 months from date of manufacture stored at or below 25°C - Ampoule, glass, 10mL - 50 dose units - 18 months from date of manufacture stored at or below 25°C
1984-03-08
Version: pfdadrni10721 Supersedes: pfdadrni10219 Page 1 of 11 NEW ZEALAND DATA SHEET 1. PRODUCT NAME DBL™ Adrenaline 1:1000 (1 mg/mL) and 1:10,000 (1 mg/10 mL) solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION DBL Adrenaline 1:1000 (1 mg/mL) and 1:10,000 (1 mg/10 mL) solution for injection is a sterile, clear, colourless aqueous solution. Each ampoule of DBL Adrenaline Injection 1:1,000 contains 1.8 mg of adrenaline acid tartrate (equivalent to 1 mg of adrenaline)/mL of water. Each ampoule of DBL Adrenaline Injection 1:10,000 contains 1.8 mg of adrenaline acid tartrate (equivalent to 1 mg of adrenaline)/10 mL of water. EXCIPIENT(S) WITH KNOWN EFFECT Each ampoule contains 1 mg/mL of sodium metabisulfite and 8 mg/mL of sodium chloride. For full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Solution for injection. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DBL ADRENALINE 1:1,000 For the treatment of acute allergic reactions, life-threatening angioneurotic oedema and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens. DBL ADRENALINE 1:10,000 Adjunctive use in the management of cardiac arrest and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens. 4.2 DOSE AND METHOD OF ADMINISTRATION DBL Adrenaline injection does not contain any preservatives. It is for single use in one patient only. Discard any residue. Do not use if the injection is brown or contains a precipitate. Version: pfdadrni10721 Supersedes: pfdadrni10219 Page 2 of 11 Adrenaline is given by subcutaneous injection. It may also be administered intramuscularly but not into the buttocks. In extreme emergencies, where a more rapid effect is required, adrenaline may be given by slow intravenous injection or by slow intravenous infusion but ONLY AS A DILUTE SOLUTION (1 IN 10,000 OR 1 IN 100,000). ACUTE ALLERGIC REACTIONS, LIFE-THREATENING ANGIONEUROTIC OEDEMA AND ANAPHYLACTIC SHOCK DBL ADRENALINE 1:1 पूरा दस्तावेज़ पढ़ें